Director Andrew Briggs Files Intent to Sell Additional $345K in Shares, Continuing Recent Selling Trend
FMAO sits 26% above its 52-week low of $22.77 on light trading volume (0.1× avg).
Summary
Director Andrew Briggs has filed a Form 144 to sell an additional $345,600 worth of shares, extending a pattern of significant insider selling over the past three months.
Key Events · Ownership and Investor Activity · FMAO
-
Director Plans Additional Share Sale
Director Andrew Briggs filed a Form 144 to sell 12,000 shares, valued at approximately $345,600.
-
Continuation of Selling Trend
This proposed sale follows previous Form 144 filings by Director Briggs, who has already sold 66,000 shares for $1.81 million in the past three months.
-
Significant Insider Distribution
The total value of shares sold and intended to be sold by this director in the last three months amounts to over $2.1 million.
-
Near 52-Week High
The selling activity is occurring while the company's stock is trading near its 52-week high.
Analysis · FMAO · Finance
This Form 144 indicates Director Andrew Briggs' intent to sell an additional $345,600 in company stock. This is a continuation of a significant selling trend by the director, who has already disposed of over $1.8 million in shares in the past three months. The cumulative selling of over $2.1 million by a director, especially as the stock trades near its 52-week high, could signal a lack of confidence or a move to realize gains, potentially impacting investor sentiment negatively.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, FMAO was trading at $28.77 on NASDAQ in the Finance sector, with a market capitalization of approximately $396.1M. The 52-week trading range was $22.77 to $29.83. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.